Search

Home > GRACEcast Lung Cancer Video > What have we learned from the START trial of immunotherapy in locally advanced NSCLC?
Podcast: GRACEcast Lung Cancer Video
Episode:

What have we learned from the START trial of immunotherapy in locally advanced NSCLC?
Category: Science & Medicine
Duration: 00:02:26
Publish Date: 2013-07-04 18:35:27
Description:

Drs. Nate Pennell, Mary Pinder, and Jack West discuss the START trial of L-BLP-25 (tecemotide) immunotherapy in locally advanced NSCLC.
Total Play: 0